Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

[Image: see text]

Detalles Bibliográficos
Autores principales: McCue, Maggie, Sarkey, Sara, Eramo, Anna, François, Clement, Parikh, Sagar V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178841/
https://www.ncbi.nlm.nih.gov/pubmed/35676662
http://dx.doi.org/10.1186/s12888-022-03975-3
_version_ 1784723144462827520
author McCue, Maggie
Sarkey, Sara
Eramo, Anna
François, Clement
Parikh, Sagar V.
author_facet McCue, Maggie
Sarkey, Sara
Eramo, Anna
François, Clement
Parikh, Sagar V.
author_sort McCue, Maggie
collection PubMed
description [Image: see text]
format Online
Article
Text
id pubmed-9178841
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91788412022-06-10 Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study McCue, Maggie Sarkey, Sara Eramo, Anna François, Clement Parikh, Sagar V. BMC Psychiatry Correction [Image: see text] BioMed Central 2022-06-08 /pmc/articles/PMC9178841/ /pubmed/35676662 http://dx.doi.org/10.1186/s12888-022-03975-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
McCue, Maggie
Sarkey, Sara
Eramo, Anna
François, Clement
Parikh, Sagar V.
Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title_full Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title_fullStr Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title_full_unstemmed Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title_short Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
title_sort correction: using the goal attainment scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178841/
https://www.ncbi.nlm.nih.gov/pubmed/35676662
http://dx.doi.org/10.1186/s12888-022-03975-3
work_keys_str_mv AT mccuemaggie correctionusingthegoalattainmentscaleadaptedfordepressiontobetterunderstandtreatmentoutcomesinpatientswithmajordepressivedisorderswitchingtovortioxetineaphase4singlearmopenlabelmulticenterstudy
AT sarkeysara correctionusingthegoalattainmentscaleadaptedfordepressiontobetterunderstandtreatmentoutcomesinpatientswithmajordepressivedisorderswitchingtovortioxetineaphase4singlearmopenlabelmulticenterstudy
AT eramoanna correctionusingthegoalattainmentscaleadaptedfordepressiontobetterunderstandtreatmentoutcomesinpatientswithmajordepressivedisorderswitchingtovortioxetineaphase4singlearmopenlabelmulticenterstudy
AT francoisclement correctionusingthegoalattainmentscaleadaptedfordepressiontobetterunderstandtreatmentoutcomesinpatientswithmajordepressivedisorderswitchingtovortioxetineaphase4singlearmopenlabelmulticenterstudy
AT parikhsagarv correctionusingthegoalattainmentscaleadaptedfordepressiontobetterunderstandtreatmentoutcomesinpatientswithmajordepressivedisorderswitchingtovortioxetineaphase4singlearmopenlabelmulticenterstudy

Ejemplares similares